Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (Weighted Average) (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 91.56% to $6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, up 91.56% year-over-year, with the annual reading at $6.1 million for FY2025, 91.56% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $6.1 million at Creative Medical Technology Holdings, up from $2.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $1.1 billion in Q1 2021, with the low at $773970.0 in Q2 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $116.3 million, with a median of $2.4 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 2694.27% in 2021, then plummeted 99.93% in 2022.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $2.6 million in 2021, then decreased by 12.29% to $2.3 million in 2022, then crashed by 38.4% to $1.4 million in 2023, then skyrocketed by 126.25% to $3.2 million in 2024, then soared by 91.56% to $6.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $6.1 million, $2.6 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.